ACM
BIOL

Archon Capital Management’s Biolase, Inc. BIOL Stock Holding History

Archon Capital Management’s Portfolio BIOL Stock Details BIOL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,070
Closed -$1M – 42
2020
Q1 		$1M Hold
1,070
– – 0.37% 27
2019
Q4 		$1.48M Buy
1,070
+408
+62% +$628K 0.25% 26
2019
Q3 		$1.56M Buy
662
+38
+6% +$125K 0.37% 26
2019
Q2 		$2.29M Buy
624
+132
+27% +$635K 0.42% 24
2019
Q1 		$2.93M Buy
492
+326
+196% +$1.58M 0.8% 21
2018
Q4 		$410K Buy
+166
New +$536K 0.17% 27

Other funds holding BIOL

OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return